Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zagzag

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Journal of Neuropathology and Experimental Neurology|December 4, 2020
Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant EpilepsyVarshini Vasudevaraja, Javier Hernaez Rodriguez, Cristiana Pelorosso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neuro-Oncology Advances|July 10, 2020
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypesJoshua D Frenster, Michael Kader, Scott Kamen, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Nature|January 25, 2002
Prediction of central nervous system embryonal tumour outcome based on gene expressionScott L Pomeroy, Pablo Tamayo, Michelle Gaasenbeek, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Cell Reports|November 8, 2023
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilityNiklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Cell Reports|November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Journal of Neuropathology and Experimental Neurology|December 4, 2020
Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant EpilepsyVarshini Vasudevaraja, Javier Hernaez Rodriguez, Cristiana Pelorosso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Neuro-Oncology Advances|July 10, 2020
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypesJoshua D Frenster, Michael Kader, Scott Kamen, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Nature|January 25, 2002
Prediction of central nervous system embryonal tumour outcome based on gene expressionScott L Pomeroy, Pablo Tamayo, Michelle Gaasenbeek, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Cell Reports|November 8, 2023
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilityNiklas Ravn-Boess, Nainita Roy, Takamitsu Hattori, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Cell Reports|November 2, 2017
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2Aram S Modrek, Danielle Golub, Themasap Khan, et al.
Pageof 19